BioSpace News Archive

Epizyme, Inc. today announced that management will present at the following upcoming investor conferences

Leading Radiology Organization Integrates Premier Outpatient Diagnostic Imaging Services Centers

The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

Ketorolac Tromethamine Tablets are a nonsteroidal anti-inflammatory drug

MEI Pharma, Inc., (Nasdaq: MEIP), a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer, today announced that Daniel P. Gold, Ph.D., the Company’s president and chief executive officer, will present a corporate update at the Wells Fargo Securities 2018 Healthcare Conference

Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced the conclusion of the ongoing investigation

Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that Michel Sadelain, M.D., Ph.D., has been appointed a member of its Strategic Scientific Advisory Board (SSAB).

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018 at 5:05 p.m. EDT at the St. Regis New York Hotel in New York, NY.

bluebird bio, Inc. today announced that members of the management team will present at the following upcoming investor conferences:

SCORR Marketing, the leading full-service marketing and communications firm in the health science industry, has announced the promotion of Krystle Buntemeyer to president.